Colorcon delivers savings, speed and flexibility for pharmaceutical film coating with Opadry QX
The system can be applied over a broad range of process conditions, including those containing temperature-sensitive active ingredients.
Colorcon Inc. is excited to announce an innovative breakthrough for pharmaceutical tablet coating, with the launch of Opadry QX, quick and fleXible film coating. This revolutionary advance greatly reduces production and preparation times, ensuring coating process efficiency and cost savings in all types of equipment, from traditional pans to continuous coating equipment. The system can be applied over a broad range of process conditions and always results in a premium quality finish for tablets, even those containing temperature-sensitive active ingredients.
Jason Teckoe, Senior Manager – Product Development explains: “Colorcon carried out extensive studies that clearly demonstrate the process adaptability of Opadry QX. The results confirm that Opadry QX provides operators with broader latitude to manage critical settings for optimal film coating such as tablet bed temperatures, spray or air flow rates.”
Latest innovation enables rapid build-up for international manufacturing
Kelly Boyer, General Manager, Film Coatings at Colorcon Inc. further notes: “The commercial impact of the process and equipment flexibility offered by Opadry QX means that multinational pharmaceutical companies can easily transition the manufacture of drug products across continents, overcoming challenges often met with equipment differences. Capital investment may also be deferred through more efficient equipment utilization as productivity demand increases."
This latest innovation clearly demonstrates Colorcon’s leadership in bringing to market film coating systems with enhanced functionality along with improved convenience, manufacturing efficiency, cost savings and dependable performance for the pharmaceutical industry.
Related News
-
News Patients vs Pharma – who will the Inflation Reduction Act affect the most?
The Inflation Reduction Act brought in by the Biden administration in 2022 aims to give better and more equitable access to healthcare in the USA. However, pharma companies are now concerned about the other potential costs of such legislation. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News CPHI Barcelona Annual Report illuminates industry trends for 2024
The CPHI Annual Survey comes into it’s 7th year to report on the predicted trends for 2024. Over 250 pharma executives were asked 35 questions, with their answers informing the industry landscape for the next year, spanning all major pharma marke... -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News EU Medical Devices Regulation causes unintended disappearances of medical devices for children, doctors state
Doctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients. -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Detecting Alzheimer's disease with a simple lateral flow test
A novel rapid diagnostic test for early-stage Alzheimer's disease has been developed using a biomarker binder from Aptamer Group along with technology from Neuro-Bio, the neurodegenerative disease experts. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance